Skip to main content
. 2013 Dec 4;8(12):e81070. doi: 10.1371/journal.pone.0081070

Table 3. Analyses of 1st-borns with and without other siblings (as of March 31st 2011).

Birth order Events During Risk Period (Days 0–2) Events During Control Period (Days 9–18) Relative Incidence (95% CI) Relative Incidence Ratio (95% CI) RIR p-value
2-month Vaccination
2nd or higher 418 1840 0.68 (0.61–0.76) 1 (Ref)
1st with siblings 248 748 0.99 (0.86–1.15) 1.46 (1.22–1.74) <0.0001*
1st with no siblings# 326 1101 0.89 (0.79–1.01) 1.30 (1.11–1.53) <0.0015∧
4-month vaccination
2nd or higher 310 1713 0.54 (0.48–0.61) 1 (Ref)
1st with siblings 198 652 0.91 (0.78–1.07) 1.68 (1.37–2.05) <0.0001*
1st with no siblings# 286 919 0.93 (0.82–1.07) 1.72 (1.44–2.06) <0.0001∧
6-month vaccination
2nd or higher 358 1808 0.59 (0.53–0.67) 1 (Ref)
1st with siblings 213 792 0.80 (0.68–0.93) 1.34 (1.11–1.62) <0.0026*
1st with no siblings# 271 1082 0.72 (0.63–0.83) 1.22 (1.02–1.45) <0.0283∧
12-month vaccination
2nd or higher 2338 1845 1.27 (1.19–1.35) 1 (Ref)
1st with siblings 1450 960 1.51 (1.39–1.64) 1.19 (1.08–1.32) <0.0007*
1st with no siblings# 1807 1353 1.34 (1.24–1.43) 1.05 (0.96–1.16) 0.2694∧
*

p-value for comparison of 1st-borns with siblings vs. 2nd or later-borns.

∧p-value for comparison of 1st-borns with no siblings vs. 2nd or later-borns.

# As of March 31st 2011.